Longmen Capital

Zhuhai Longmen Capital Management Co., Ltd. is a venture capital firm established in 2017, with offices in Zhuhai and Shenzhen, China. The firm specializes in early and growth stage investments, primarily targeting the healthcare sector, which encompasses pharmaceuticals, biotechnology, medical equipment, medical services, and life sciences, with a particular emphasis on gene therapy. Longmen Capital aims to support innovative companies that are poised to make significant advancements in these fields.

Lijie Cui

Partner

Haining Wang

Founding Partner

1 past transactions

SmartNuclide

Series A in 2018

Developer and researcher of biopharmaceuticals for molecular nuclear oncology intended to serve the biotechnology industry. The company specializes in developing innovative biological drug products including both diagnostics and therapeutics formulations targeting molecular oncology, providing reliable and effective products for better cancer treatment.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.